Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 direct-acting antiviral experienced hepatitis C patients | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 direct-acting antiviral experienced hepatitis C patients

Belperio PS, Shahoumian TA, Loomis TP, Backus LI. Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 direct-acting antiviral experienced hepatitis C patients. J Viral Hepat. 2019;26(8):980-990.

Publication Type:

Journal Article

Authors:

Belperio, PS; Shahoumian, TA; Loomis, TP; Backus, LI

Source:

J Viral Hepat, Volume 26, Issue 8, p.980-990 (2019)

Cited On:

Sofosbuvir-Based and Elbasvir/Grazoprevir Treatment Failures

Export Citation:

RIS Format

Top